SCHEMBL6027697

SCHEMBL6027697

O=C(O)c1c[nH]cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.56
TP53 P04637 1/20 0.56
TSHR P16473 1/20 0.56
CASP1 P29466 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ALPL P05186 1/20 0.49
SRD5A2 P31213 2/20 0.47
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
AKR1C4 P17516 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
MYC P01106 2/20 0.45
NR4A1 P22736 1/20 0.45
DHODH Q02127 1/20 0.45
MARS1 P56192 1/20 0.44
DYRK1A Q13627 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219180 0.77 CNR1 (0.48) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL442223 0.77 ALDH1A1 (0.58) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL9336033 0.77 ALDH1A1 (0.49) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL9558834 0.77 TSHR (0.68) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL19514758 0.75 ALDH1A1 (0.71) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL17785974 0.73 ALDH1A1 (0.53) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL10900803 0.73 DYRK1A (0.61) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL224469 0.73 ALDH1A1 (1.00) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL111279 0.73 TSHR (1.00) ALDH1A1TP53TSHRCASP1SMN1; SMN2
SCHEMBL29986499 0.73 HSD11B1 (0.50) ALDH1A1TP53TSHRALPLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1618127-A2 THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS CHIRON CORPORATION (US) 2006-01-25 EP disclosed
EP-1537099-A1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2005-06-08 EP disclosed
WO-2004092360-A2 THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS CHIRON CORPORATION (US) 2004-10-28 WO disclosed
WO-2004018455-A1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2004-03-04 WO disclosed